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ABSTRACT 
Background 
Early HIV testing is a crucial step for pregnant women in preventing mother-to-child 
transmission of HIV. In the public sector nearly all pregnant women presenting at antenatal 
clinics are screened for HIV. However, according to a large medical-aid administrator in 
South Africa, only 21.96% of pregnant women on their medical aid claimed for an HIV test 
as part of their antenatal care in 2012. Despite having frequent opportunities when consulting 
with pregnant women, general practitioners tend to be reluctant to offer HIV screening to 
these privately insured patients. In South Africa, private sector general practitioners are 
reimbursed for their services at pre-determined, negotiated rates. Previous studies indicate 
that monetary incentives over and above the negotiated rate may motivate health providers to 
promote screening to patients, and this may lead to increases in the uptake of testing. Due to 
limited resources within the public health sector, general practitioners are seen as key 
resources in a public private partnership to assist government achieve strategic health 
outcomes such as improved access to quality healthcare and improved compliance to 
treatment plans. 
Methodology 
A quasi-experimental, ‘before and after’ study design, was conducted among 2,934 
Metropolitan Health network general practitioners in South Africa who managed a pregnant 
woman on a medical aid. The same population of general practitioners were used in the pre 
and post analysis with the general practitioners receiving information about the benefits of 
HIV testing in pregnant women before and after. The only difference was with the 
intervention related to a new HIV Counselling and Testing incentive process. Data was 
extracted   from the billing system of a private medical insurance company in South Africa>. 
Quantitative data and stratification was analysed using the Statistical Package for the Social 
Science software, version 16.0 and Epi Info version 7.1.0.6. The effectiveness of the 
intervention was assessed by comparing the pre intervention period between April 2011 and 
September 2012, and post intervention period between March 2013 and August 2014.  A 
subgroup analysis was done to determine variations in the name it, by general practitioners 
and patient characteristics.  
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Results 
There was no significant difference in HIV testing by general practitioners in this network pre 
and post the intervention (21.99% vs. 21.96%, p=0.939). Compared to general practitioners 
aged 25-44 years, general practitioners older than 65 years old were 13% less likely to test 
(OR 0.87, CI: 0.74-1.01) and general practitioners between 45 and 65 years were 9% less 
likely to do an HIV test (OR 0.91, CI: 0.85-0.98). This study found that as patients’ age 
increased, they were more likely to be tested: beneficiaries aged 35- 44 years were 15% more 
likely to be tested compared to beneficiaries aged 15-24 years (OR 1.15, CI: 1.1-1.21). 
Beneficiaries who had a vaginal delivery were less likely to be tested compared to women 
who chose caesarean as a delivery method (OR 0.87, CI: 0.84-0.9). Medium income 
beneficiaries were more likely to be tested compared to low income beneficiaries (OR 1.09 
CI: 1.03-1.16) and beneficiaries from the “high income” scheme grouping were less likely to 
be tested (OR 0.87, CI: 0.82-0.92) compared to the low income scheme grouping. The timing 
and frequency rates of HIV testing, for both caesarean and vaginal deliveries, occurred most 
between months two and six, peaking at month four. Overall, Eastern Cape and Mpumalanga 
had the lowest testing rates compared to all the other provinces (OR 0.96 CI: 0.89-1.05). 
Conclusions 
Most general practitioners’ HIV testing rates of pregnant women in the private sector 
behaviour analysed in this study remained the same, despite the presence of a financial 
incentive. This study’s findings suggest that healthcare provider behaviour to comply with 
clinical guidelines and best practice, has no association with the presence of financial 
incentives, especially with increased administration tasks to access the incentive. These study 
findings emphasise the need to continue to strive for improved compliance especially by 
older general practitioners’ to adhere to clinical best practice and national HIV screening 
guidelines of pregnant women. The aspiration of achieving the highest quality of care in both 
private and public sector are principles that should continue to be pursued especially where 
private sector general practitioners’ will be used to offer public health services in the future 
National Health Insurance. 
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CHAPTER ONE: INTRODUCTION 
1.1. Background 
The Human Sciences Research Council (hereafter HSRC), South African National HIV 
Prevalence, Incidence and Behaviour Survey for 2012,  reported that South Africa has a HIV 
prevalence of 12.2% (6.4 million), which was 1.2 million more people living with HIV 
(hereafter PLHIV) compared to 2008 (10.6% or 5.2 million) (1). The HSRC estimated the 
prevalence of HIV was the highest among females aged 30–34 and in the female teenage 
population. The estimated HIV prevalence among females was 8 times that of their male 
counterparts, suggesting that female teenagers aged 15–19 years are more likely than their 
male counterparts to have sex, not with their peers, but with older sex partners (1). This data 
was correlated by 2012 National Antenatal survey that stated, the HIV prevalence among the 
15-24 year old pregnant women remained stable approximately 20% and that HIV prevalence 
among women in the age group 30 - 34 years remains the highest, with a slight increase from 
42.2% in 2011 to 42.8% in 2012 (2). Five provinces (Free State, Gauteng, KwaZulu-Natal, 
Mpumalanga and North West) out of the nine have recorded HIV prevalence estimates above 
the national estimate of 29.5% as illustrated below in table 1 (2).  
Table 1.1: HIV prevalence estimates among antenatal women by province, 2010 to 2012. 
2010 2011 2012 
N %PREV 95% CI N %PREV 95% CI N %PREV 95% CI 
South Africa 32225 30.2 29.4-30.9 33326 29.5 28.7-30.2 33865 29.5 28.8-30.2 
Eastern Cape 3994 29.9 28.2-31.7 4099 29.3 27.5-31.1 4552 29.1 27.3-30.9 
Free State 2223 30.6 28.3-33.0 2292 32.5 30.5-34.5 2309 32.1 29.8-34.3 
Gauteng 6714 30.4 29.1-31.8 6948 28.7 27.3-30.1 6755 29.9 28.3-31.5 
Kwazulu- Natal 6887 39.5 38.0-41.0 6714 37.4 35.8-39.1 6990 37.4 36.1-38.7 
Limpopo 3117 21.9 20.3-23.6 3651 22.1 20.6-23.7 3553 22.3 20.7-23.9 
Mpumulanga 2202 35.1 32.6-37.7 2116 36.7 34.3-39.2 2182 36.6 33.3-37.9 
North-West 1963 29.6 27.3-31.9 2352 30.2 28.2-32.4 2443 29.7 27.5-32.0 
Northern Cape 1144 18.4 16.1-21.1 1125 17.1 14.3-20.1 1173 17.8 15.3-20.7 
Western Cape 3981 18.5 15.1-22.5 4029 18.2 14.3-22.8 3908 16.9 13.8-20.5 
Source: National Department of Health. National Antenatal Sentinel HIV and Syphilis 
Prevalence Survey 2012 
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. 
The United Nations Children’s Fund (hereafter UNICEF), has warned that across sub-
Saharan Africa mother-to-child-transmission (hereafter MTCT) of HIV remains an on-going 
threat to child health (3).  
UNICEF has requested all governments commit to striving for an AIDS-free generation with 
the main component of the response being elimination of mother-to-child transmission (3). 
HIV infection in pregnancy drives premature birth, neo-natal complications, and increased 
risk of opportunistic infections in the first year of life which results in an increased risk of 
infant mortality (3).  
According to the Department of Health, antenatal care is used to identify risk factors and 
early diagnosis of pregnancy complications and appropriate management, and health 
education (4). The national Department of Health essential antenatal screening investigations 
include: Syphilis serology, Rhesus blood group; haemoglobin level; and HIV testing (4).  
1.2. Antenatal Care options in South Africa 
According to Barron et al., pregnant women in South Africa, access antenatal screening care 
from two options: either via private or public care. Antenatal and postnatal care is free for 
pregnant women accessing public health facilities (5). In the public sector, pregnant women 
are managed by nurses in consultation with a medical officer used as a referral medical 
specialist and may not always have access to a gynaecologist or obstetrician.  
In South Africa, private sector physicians are reimbursed for their services at negotiated rates 
that are pre-determined for the type of service offered, known as a fee for service (3). In 
South Africa, private general practitioners s typically have a mixed clientele of insured and 
uninsured patients (6). Services to insured clients are most commonly reimbursed directly by 
insurers (known as medical aid schemes) on a fee-for-service basis (6). Uninsured (or cash 
paying) clients are provided with an all-inclusive package of care (consultation and drugs) in 
return for a fixed cash fee. A high proportion of the uninsured as well as the insured utilise 
private care. In the private sector, antenatal screening and HIV testing benefits are part of 
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Prescribed Minimum benefit packages across all medical programmes, which is a set of 
health care entitlements that all insurers would have to include and fund in any health 
insurance package (7). According to Chabikuli et al., within the South African private sector 
the primary provider is a general practitioner with a gynaecologist or obstetrician as the 
referral specialist. Independent private health care providers (i.e. doctors, dentists, 
pharmacists, etc.) meet the primary care service needs for 8.1 million insured South Africans 
(6), whereas, the public health model looks after the balance of the 42 million uninsured 
patients. Chabikuli et al., also noted that despite considerable efforts to improve access to 
public sector care for example , sexually transmitted diseases (STDs), general practitioners’ 
in South Africa are still important providers of such care, possibly treating more STD cases 
than the public sector (6). Ease of access, privacy, confidentiality and short queues are some 
of the features of the private sector that generally attract patients with STDs (6). Soderlund et 
al., found that approximately 56% of doctors in South Africa work in the private sector, and 
are better qualified and more experienced, on average, than their public sector counterparts 
(7). This illustrates the need to incorporate highly skilled general practitioners into the 
national health insurance model. 
1.3. Non-Compliance to guidelines 
Basu et al., found that in low income countries diagnostic accuracy and adherence to medical 
management standards were worse among general practitioners’ compared to public sector 
doctors (8). Most of these studies examined infectious disease management protocols, 
including for HIV, tuberculosis and malaria. They also found that private practitioners had 
significantly worse knowledge of correct diagnosis and treatment of infectious disease 
compared to non-communicable conditions (8). 
Despite frequent opportunities for pregnant women consulting their general practitioners the 
preliminary Metropolitan Health data for 2012 suggest that general practitioners tend to be 
reluctant to offer HIV screening, especially to their pregnant patients. 
According to survey studies from India by Datye et al., the following are common reasons for 
general practitioners’ not offering a HIV test. Firstly, general practitioners’ assume that the 
patient’s gynaecologist will manage the pregnancy and thus perform the antenatal care, 
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secondly general practitioners’ ascribe lack of time to conduct tests, thirdly general 
practitioners’ do not wish to manage a HIV positive patient’s queries and finally general 
practitioners’ are reluctant to discuss HIV due to fear of offending the respective patient. 
1.4.  Pay for Performance 
The concept of linking financial incentives to the quality of healthcare provided has been 
termed pay for performance (7).  Compensation models that link financial incentives to 
performance have been widely implemented in other industries and are a powerful lever to 
influence behaviour payment for performance is seen as a way to create a “business case” for 
quality by better aligning payment with quality of service instead of quantity of service (9). 
According to Glickman et al., pay-for-performance programmes may have the potential to 
improve overall quality of care by narrowing gaps between what national care guidelines 
recommend and those treatments actually delivered in routine community practice (9). 
However, while the Department of Health has strongly recommended all sectors, including 
the private sector, to target test adults with risk factors for HIV infection, such as pregnant 
women, this study has established that this directive has not been complied within the private 
sector. 
1.5. Problem statement 
A leading Health Insurance Administrator Company’s preliminary data suggest low antenatal 
screening HIV testing rates of pregnant women (Table 2). From the claims data received 
from general practitioners’ and pathology laboratories, the data below suggests that all 
infectious disease screenings, in pregnant women is being under-screened, including the HIV. 
Table 2: Billing information of HIV screening of pregnant women behaviour by general 
practitioners’ from the Health Insurance risk management system 
 
 
Private Sector 2012 Actual ANC Tests % ANC Tests 
Total Pregnant Population 35969 
 HIV 7908 21.99% 
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This research study demonstrated the low baseline level of HIV testing in the private sector 
and what impact a financial incentive intervention would have on changing the behaviour of 
general practitioners’ to increase HIV testing provision. The analytic goal was intended to 
evaluate the effects of the intervention by comparing pre- to post changes specifically on the 
rate of HIV testing. 
One of primary end points of the study was to determine if private sector general 
practitioners’ have the potential to change their clinical behaviour with respect to 
preventative HIV testing screening of pregnant women; and whether an incentive would 
motivate the general practitioners’ to initiate testing. Financial incentives that are linked to 
the quality of care rendered by the general practitioners’, can serve as an effective approach 
to modifying the behaviour of general practitioners’ that controls the type, quantity and 
quality of healthcare services being provided. By rewarding the general practitioners’ for 
taking extra time to offer and perform a HIV test; this study aimed to address and remove any 
barriers to adherence to the national clinical guidelines.  
 
1.6 Conclusion 
One the benefits of the study was that, general practitioners’ would move away from targeted 
HIV testing based on symptomatic, social or lifestyle risk factors and move towards routine 
screening for all pregnant women.Promotion of more routine screening has additional 
benefits over targeted testing because HIV-positive patients have high consultation visits, due 
to increased risk of opportunistic infection, prior to diagnosis and routine screening may 
identify persons who are unaware of their risk or who do not disclose high risk behaviours if 
they are asked. It is hoped that this financial incentive provided evidence that would justify 
the additional cost by demonstrating an improvement in the quality of service aligned with a 
specific health outcome. 
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CHAPTER TWO: LITERATURE REVIEW 
2.1 Introduction 
This chapter will deal with four themes. Firstly, defining pay for performance secondly, 
possible factors associated with poor compliance to clinical guidelines, thirdly, benefits and 
challenges related to pay for performance models and lastly, the theories used to explain the 
multiple interventions required to change healthcare provider behaviours. 
The data source approach included descriptive information about paying for health care 
quality. We used Google Scholar, PubMed and Plos online for scientific literature using 
combinations of the following keywords: Doctor, General Practitioner, pay for performance, 
pay for quality improvement, financial incentive bonus, quality of care, provider payment, 
and performance improvement. Once the list of sources was identified, the various abstracts 
were read to determine if the study matched one of the four themes mentioned above. 
2.1. Pay for Performance Programmes 
The research of theme one attempted to understand the various incentive funding models and 
the design of the incentive models within the healthcare market. 
In order to improve the gap that exists between evidence-based medical practices and the care 
that many patients actually receive, large health insurance purchasers such Metropolitan 
Heath, are experimenting with reimbursement arrangements called pay for performance that 
tie a portion of payments for physician services to measures of quality (9,10). In order to 
manage rising healthcare costs, pay for performance are viewed as a tool to promote more 
efficient use of healthcare resources while improving patient outcomes (9).  
Christianson et al., found that pay for performance standards for physicians focused on 
process, acceptance of information technology and outcome measures related to chronic 
disease management, as well as primary prevention, such as screening and immunisations 
(10). These pay for performance principles have been accepted and implemented in several 
countries in various models. More than half of commercial health plans in the United States 
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currently use pay for performance incentives in their provider contracts. According to 
Rosenthal et al., the largest demonstration project in America is the Hospital Quality 
Improvement Demonstration (hereafter HQID) Project, which offers financial incentives to 
hospitals based on the inpatient quality of care for five clinical conditions; acute myocardial 
infarction, heart failure, pneumonia, coronary artery bypass surgery, and hip and knee 
replacement (11). Analysis by McDonald et al., found that over £2 billion has been 
distributed to providers in England since 2004 who participated in the National Health 
Service (hereafter NHS) pay for performance Quality Outcomes Framework (QOF) model 
(12). The QOF model provided financial incentives to primary care physicians who achieved 
146 quality indicators related to chronic disease and patient experience (12). 
2.2. Factors associated with poor compliance to clinical guidelines 
The second theme's research attempted to understand the factors associated with poor 
compliance to clinical guidelines which may explain the current low uptake of HIV screening 
in pregnant women. According to Berendes et al., poor compliance to guidelines by health 
care providers plagues the delivery of health services (13). Poor compliance to clinical 
guidelines is not simply due to inadequate training or deficiencies in provider knowledge 
(13). Below we unpack the evidence associated with poor guideline compliance. 
There are several factors that influence poor compliance of HIV testing by general 
practitioners’, namely, interpersonal skills of general practitioners’, lack of time and the 
logistics of offering a HIV test in a private practice (6). According to Martin et al., the 
interpersonal dynamics of the GP–patient relationship play an important role in determining 
patient acceptance of testing (14). According to Datye et al., general practitioners’ also 
experience discomfort discussing ‘difficult’ issues, general practitioners’ who have prejudices 
around HIV-related risk behaviours and ‘risk groups’ have been known to affect the quality 
of patient care and impede communication between the general practitioners’ and their 
patients (15). The ability of the general practitioners’ to earn the patients’ trust is essential to 
ensure their emotional disclosure and is therefore a crucial component of the patient–GP 
relationship (14). 
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Besides the general practitioner, the type of patient also plays a role in discussion between the 
general practitioner and patient around HIV testing. Research by Mkwanazi et al. found that 
older and more educated women were less likely to accept testing, suggesting the need to 
specifically target these patients (16). Lack of interpersonal skills by general practitioners’ to 
address sensitive issues with patients is suggested to be a major factor in poor adherence to 
the antenatal guidelines with regards to offering HIV testing to pregnant women (16). 
Patients who feel that their physicians communicate well with them and actively encourage 
them to be involved in their own care tend to be more motivated to testing (14). 
According to Armington, 2005, the logistics of performing HIV testing is another deterrent, 
due the fact that implementing rapid HIV testing requires planning; firstly, there is the issue 
of space in the general practitioner practice to consider, as patients require a confidential 
space to review the written materials, including the informed consent and to receive the 
necessary pre-test counselling (17). Another factor, according to Armington, is the time 
involved in counselling and testing as he estimates that 5 to 10 minutes is required for pre-test 
counselling, 5 to 20 minutes is required for post-test counselling, and a further 5 to 20-
minutes of processing time is required in between, depending on the test used (17). Thus, it is 
important for general practitioners’ to provide a separate consultation area to ensure 
confidentiality is maintained and a comfortable space for the patient to be counselled in. 
A study by Rayment et al., investigating barriers to implementation of HIV testing by clinical 
staff, found challenges in the provision of HIV testing, related to a lack of time to conduct 
testing and being ill-prepared to answer patient queries.  General practitioners felt that 
consent to test was too burdensome and time consuming to answer related questions (18). 
2.3. Benefits and challenges related to pay for performance models 
The research of the third theme, attempted to present both the benefits and challenges 
associated with P4P models. In the health insurance industry it has been accepted that some 
form of incentive models show promise to improve healthcare quality and reduce costs. 
However, it seems multiple approaches may be required to provide value for key 
stakeholders, including patients, providers, and payers (19). Despite monitoring and 
 
 
 
 
9 
evaluation mechanism being in place, even sophisticated pay for performance models does 
not eliminate the incentives for overtreatment, under treatment or abuse of the system (19). 
2.3.1.  Benefits of Pay for Performance models 
According to Brindis et al., linking financial incentive to quality is also viewed by many as a 
more acceptable approach compared to traditional managed care models where financial 
incentives are provided to physicians to limit referrals and to see more patients per day (19). 
Grumbach et al., found the acceptance of incentives by doctors high when the model 
encouraged preventative care medicine, such as screening (20). This model encouraged better 
care for the patients and contributed to their overall net income for their practice (20). 
Pay for performance models also holds promise because many of the traditional approaches 
to improving quality, such as physician education, provider certification and consumerism, 
have failed, largely due to the fragmented nature of the healthcare delivery system (19). 
2.3.2.  Challenges related to pay for performance models 
Rosenthal et al. noted that most pay for performance initiatives reward achievement of a 
benchmark, and not quality improvement per se; physician practices that start at a lower 
level, but show substantial improvement, are less likely to be rewarded by these initiatives 
(11). A study by Chabikuli et al. found differences between the quality of care offered to 
insured and uninsured patients when general practitioners screened and treated patients with 
sexually transmitted infections (STIs) (6). The general practitioners’ in this study prescribed 
cheaper but ineffective treatment regimens to uninsured patients but not to insured patients. 
Thus, suggesting that the cost of drugs, together with the financing mechanism, is at least one 
determinant of the quality of care offered. In addition, this study found that the fee for 
services on its own, in the absence of any incentive linked to a health outcome, can however 
contribute to over-treatment, excessive costs and wastage of resources. This was particularly 
prevalent by pharmaceutical company’s incentivising general practitioners’ to prescribe their 
expensive drugs to insured clients.  According to Kenefick et al., under traditional fee for-
service reimbursement arrangements, financial incentives primarily are tied to the volume of 
procedures that rewards physicians for doing more and not necessarily for doing the right 
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thing (21). The aforementioned data suggests that activity based financial reimbursement 
models alone, may encourage perverse behaviour and may not achieve the desired health 
outcomes 
One of other challenges to financial incentive models relate to how high the level of payment 
be to achieve the desired outcome. According to Young and Conrad, if a research study finds 
that, in a particular situation, providers did not respond to a financial incentive by changing 
their behaviours, it might seem reasonable to recommend that policy-makers increase the 
payment in order to achieve their goal (22). However, this would not be warranted if the 
value of the gains from the behaviour change was not sufficient to justify the higher payment, 
which in this case is the cost of avoiding a HIV positive baby being born (22). 
Hillman et al., found incentives directed at the individual physician-level versus physician’s 
group’s practices were found to be the most effective (23). In this study by Hillman et al., 
they randomly assigned general practitioner practice sites serving children in a medical aid 
health maintenance organization (HMO) to one of three groups: a feedback group (where 
general practitioners’ received written feedback about compliance scores), a feedback and 
incentive group (where physicians received feedback and a financial bonus when compliance 
criteria were met), and a control group (23). They then monitored compliance with paediatric 
preventive care guidelines through semi-annual chart audits during the years 1993 to 1995 
(23). The Hillman et al. study, which combined the intervention of financial incentives and 
feedback, did not improve screening significantly (23). The authors speculated that the 
financial incentives may have been too small or the incentive was poorly communicated to 
physicians. 
According to Kenefick et al., if quality is the goal, payments need to be structured to 
maximize quality of care, not quantity (21). Kenefick et al. also agreed that small incentives 
have been shown to be ineffective in changing healthcare provider behaviour (21). 
Christianson et al., concurred around a cautious expectation as their research found that 
procedural aspects of care delivery seemed to have improved, but that there was little 
evidence regarding impact on the health of patients (10).  
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 2.4.  Multiple interventions required to change healthcare provider behaviours 
The research of the fourth theme, attempted to bring the various successful methods together 
in an effective multiple intervention approach. 
Doctors experience of financial incentives and pressure related to their practices differed 
according to practice settings and the level of income they can generate from incentives (20). 
Research on pay for performance by Dudley in 2005, found financial incentives have the 
potential to influence the recommendations providers when reaching a decision with their 
patient about the utilisation of services (24). The degree of change in the provider behaviour 
observed depends on many factors in addition to the amount of financial reward at stake, 
including the willingness of patients to accept the advice of their primary care physicians and 
the ability of primary care physicians to reconcile their recommendations with their role of 
patient advocate, for the patient’s best interest (24).  
An important outcome is adherence to guidelines, and research by Kahn et al., who 
conducted an observational cohort study evaluating hospital quality and financial 
performance of two incentive programmes namely: the Premier Hospital Quality Incentive 
Demonstration programme and the Medicare Payment Advisory commission programme 
concluded that pay for performance had the potential for improving quality of care and 
generating greater funding for hospitals (25). The financial data of 4 203 hospitals and quality 
guideline adherence scores for heart attack, heart failure and pneumonia were examined. The 
top 10 per cent performing hospitals received a bonus equal to 2 per cent of payments made 
for discharges of patients with the corresponding condition, and those between the eightieth 
and ninetieth percentiles got a 1 per cent bonus (25). The study found that pay for 
performance models linked to quality health guidelines generated greater hospital funding 
than hospitals without pay for performance (25). 
A systematic review of the effectiveness of healthcare in the National Health Service by 
University of York in 1999 concluded that passive dissemination of clinical guidelines was 
generally ineffective (26). The review found that it was unlikely to result in behaviour change 
when used alone, but it may be useful in raising awareness of the desired behaviour change, 
in terms of adherence to the clinical guidelines, especially diagnosis and treatment (26). 
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Davis et al., found that certain single interventions such as educational outreach meetings, 
opinion leaders, patient-mediated interventions and reminders are likely to be effective in 
changing healthcare provider behaviour (27). However, multi-faceted interventions were 
more likely to be successful (27). 
When general practitioners’ were remunerated by government for their services related to 
primary care, HIV testing was high. Research by Hettige found that in countries where 
private sector HIV testing use was highest, the private sector was also highly utilised for 
other health services such as antenatal care, infectious disease, family planning, and sexually 
transmitted infection treatment (28). 
A study by Sutton et al. found that pay for performance in all National Health Service 
hospitals in one region of England was associated with a clinically significant reduction in 
mortality (29). As compared with a similar United States programme, the United Kingdom 
programme had larger bonuses and a greater investment by hospitals in quality-improvement 
activities (29). The pay for performance model involved the early identification and targeting 
of high risk patients groups that eventually improved mortality and morbidity outcomes (29). 
A study by De Walque et al., examining the impact of a pay for performance intervention on 
individual and couple HIV Counselling and Testing found a positive impact of pay for 
performance with an increase of 6.1% in the probability of individuals having ever been 
tested (30). The results also indicated larger impacts of pay for performance on the likelihood 
that the respondent reports both partners have ever been tested, especially among discordant 
couples in which only one of the partners is HIV positive (30). 
A systematic review of pay for performance programmes by Flodgren et al. found that 
payment for each service, episode or visit was generally effective, as was payment for 
providing care for a patient or specific population (31). However, a study by Doran et al. 
found that incentive initiatives in primary care resulted in early success, however 
improvement plateau for incentivised performance measures and quality deteriorated for non-
incentivised measures like continuity of care (32). Simplicity of the model was also important 
to general practitioners’ as compliance and understanding is affected when they are exposed 
to different incentives from various medical aids (19). 
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 2.5.  Summary 
The study aimed to create awareness by the general practitioners to change their clinical 
behaviour with respect to preventive, diagnostic and treatment decisions, or both. Based on 
the preceding data, a large monetary incentive along with current guideline dissemination 
linked to a health outcome could be an effective intervention that could increase the 
adherence to antenatal clinical guidelines, which include offering a HIV test to all pregnant 
mothers. In addition practical implementations factors in the general practitioners’ practice 
could also impact on poor adherence to the antenatal guidelines by general practitioners’ such 
as poorly designed workflow and care systems, undue commercial influence, knowledge 
gaps, memory lapse, lack of time, poor interpersonal skills as well as whether the patient has 
medical insurance. These general practitioners claimed for consultations related to antenatal 
care using the MH billing system for re-imbursement of services rendered. 
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CHAPTER THREE: METHODOLOGY 
In this chapter, a description of the aim and objectives of the study is covered. This section 
covers the study design, study population, sample size, procedure, data collection and 
processing, data analysis, validity, as well as ethical considerations. 
 3.1.  Aim and objectives of this study 
The aim of the study was to determine the effectiveness of a monetary incentive to change the 
behaviour general practitioners, resulting in an increased uptake of HIV testing among 
pregnant women who have private medical-aid insurance throughout South Africa. 
The objectives of the study were to firstly determine if there was an increase in the uptake of 
HIV testing among pregnant women receiving antenatal care at general practitioner practices 
following the offering of a monetary incentive to the general practitioners, secondly to 
determine variations in the uptake of HIV testing based on characteristics of pregnant women 
and the general practitioner. The hypothesis was that the financial incentive would encourage 
general practitioners’ to increase HIV testing rates of pregnant women. 
 3.2.  Study Design 
According to Beaglehole et al., intervention or experimental study designs involves 
attempting to change a variable in one or more groups of people (33). The effects of an 
intervention are measured by comparing the outcome in the experimental group with that in a 
control group (33). Non-randomised before and after studies measure general practitioner 
performance before and after the introduction of an intervention (e.g. incentive) in the same 
study site(s) and any observed differences in performance are assumed to be due to the 
intervention (34). In this case the control group of general practitioners’ was same as the 
intervention group with their behaviour before the intervention being used as the baseline or 
historical control response. A quasi-experimental, before and after study design, was used to 
examine the effectiveness of a monetary incentive on the behaviour of general practitioner. 
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According to Terre Blanche et al., experimental study designs such as before and after studies 
assisted in evaluating the impact of the incentive, cause and effect sequence (34). 
However experimental studies tend to be expensive and difficult to organise due to ethical 
and informed consent challenges. These challenges were overcome as this study evaluated 
the impact of the incentive using routine data from the Health Insurance billing system in 
addition the data remained confidential and no- identifiable information of the patient or 
general practitioner will be published to maintain anonymity. 
In the case of this incentive model, no patient was denied access to care; the medical scheme 
approved additional benefits for the incentive over and above normal antenatal care benefits. 
The intervention or incentive was already implemented and the research is analysing and 
comparing the impact of incentive on the exposed and unexposed group of general 
practitioners’. The benefit to the patients of increased testing and awareness of their status 
empowers the patient to access treatment early in their disease. 
 3.3.  Study Population 
The general practitioners’ in South Africa are contracted to a fee for services with a large 
health insurance administrator. According to council of medical schemes there are 3500 
general practitioners, as at October 2013, who are registered with the Health Professions 
Council of South Africa and who claim from medical schemes in South Africa (35). 
The target population for the study were the general practitioners’ who are contracted to the 
Health Insurance Provider Network and who consulted at least 1 pregnant woman for the 
year. As at February 2013, there were 2,630 distinct general practitioners’ who met these 
criteria. Pregnancy related consultations was identified, by searching the Health Insurance 
company’s data base for specific pregnancy related ICD-10 (International Classification of 
Diseases) codes the general practitioners’ used on their consultation claims they submitted to 
Health Insurance administrator company for payment of services rendered. This ensured with 
reasonable confidence that the general practitioner had confirmed the patient was pregnant. If 
a general practitioner did not use a pregnancy related code or used an unspecified ICD-10, we 
could not assume with reasonable confidence the general practitioner was aware of the 
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patient’s pregnancy state. This was done to avoid measurement bias or potential systematic 
errors.  
Intervention: The intervention involved an email communication sent to all network general 
practitioners’ who consult with at least one pregnant woman per annum. General 
practitioners’ started receiving emails in October 2012 and then repeated monthly until 
February 2013. The email informed the general practitioners’ of the benefits of HIV 
screening of pregnant women as well how to access the HIV testing incentive via the HIV 
Counselling and Testing web portal. Included in the email was a link to a self-training manual 
demonstrating and explaining how to use the HIV Counselling and Testing portal. All 
network general practitioners’ had to have had a contact with a pregnant female beneficiary 
during a nine month period before delivery date.  Follow-up time was divided into a pre- and 
post-intervention period, allowing for a 21-month interval of contact time with a network 
general practitioners’ per period.  Pre intervention period included deliveries between 1 April 
2011 and 31 September 2012 and post intervention period deliveries between 1 March 2013 
and 31 August 2014.  Data from all provinces were included for analyses for women between 
the ages of 15 and 55 years. The network general practitioner, intervention group, would 
receive R200 if they performed an HIV test on a pregnant patient, over and above their 
normal consultation fee. 
3.4. Sampling Procedure 
Burns and Grove described eligibility criteria or inclusion as list of characteristics essential 
for eligibility in the study population (36). A quasi experimental study is similar to a 
controlled experimental design except that we were unable to randomly assign the general 
practitioner to either the experimental or the control group, therefore we were unable to 
control which group will receive the incentive (34). The general practitioners’ do not all have 
the same chance of being in the control or the experimental groups, or of receiving or not 
receiving the incentive. This study’s non randomised sample population consists of 2934 
distinct general practitioners’ who consult with at least one pregnant woman per annum. The 
email informed the general practitioners’ of the benefits of HIV screening of pregnant women 
as well how to access the HIV testing incentive via the HIV Counselling and testing web 
portal.  
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 3.5.  Sample Size 
The minimum sample size to provide a 95% confidence level for the pre- and post-
intervention groups was estimated using Epi Info version 7.1.0.6 Stat Calc. The following 
parameters were used: to a achieve 80% power and to detect a relative risk of 2 in a study 
with an allocation ratio of 1:1 non-exposed to exposed subjects, and with an expected 
incidence in the non-exposed group of 10%, with 1 - a = .95, EpiTable determined the 
minimum sample size of n1 = n2 was estimated to be 250. A group of 2321 network general 
practitioners qualified for both and pre and post intervention groups while only 304 network 
general practitioners qualified for the pre-intervention period and 309 for the post 
intervention period. All the data records were eventually used. 
 3.6.  Data Collection 
Permission to conduct the study was obtained from the, General Manager of Out of Hospital, 
at Health Insurance Administrator Company (Appendix 1). According to Ferver et al., claims 
or billing databases are electronic records of transactions that have occurred between patients 
and healthcare providers (37). A major use of claims data is as a substitute for the 
information contained in patients’ medical records. Medical records are often not available in 
electronic format, which makes them harder to access (37). 
General practitioners’ would capture the data required using the HIV Counselling and Testing  
web portal that was linked to a centralised data base housed by the Health Insurance 
Administrator Company. This routine data collected would include administrative, billing and 
clinical data from the pre-existing centralised within Health Insurance Administrator 
Company’s data warehouse. The Health Insurance Administrator Company has an electronic 
integrated billing system that is able to provide a 'single view' of the member and service 
provider records. Real time validation of members and service provider records is performed 
during claims processing against the billing system master files. The Health Insurance 
Administrator Company billing system is currently receiving claims electronically through 
electronic data interchange (EDI) partners and the internet. 
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The data of the number of HIV tests being performed for pregnant women, was divided into a 
pre- and post-intervention period, allowing for a 21-month interval of contact time with a 
Foundation DSP network general practitioner per period.  Pre intervention period included 
deliveries between 1 April 2011 and 31 September 2012 and post intervention period 
deliveries between 1 March 2013 and 31 August 2014.  Data from all provinces were 
included for analyses for women between the ages of 15 and 55 years. 
3.7. Data Analysis 
Data was analysed to test the hypothesis of whether or not financial incentive would 
encourage general practitioners’ to increase HIV testing rates of pregnant women. A sequel 
query to extract the data from the Health Insurance Administrator Company data warehouse 
was scripted by a data analyst. The routine data used in the analysis included patient 
demographics, clinical data, date service rendered, patient demographics, laboratory tests, 
diagnostic codes and billing tariffs for patient contacts and the link to the treatment 
programmes for the period 01 April 2011 to 31 August 2014.  
The quantitative data extracted was sorted into five variables namely: Demographic data 
related to the patient such as: Identity Number, Age, Income band and Province of residence. 
Data related to the pregnancy such as, procedure codes to identity pregnancy, year of 
pregnancy, expected date of delivery, obstetric type (miscarriage, termination of pregnancy, 
vaginal delivery and caesarean section), demographic data related to the general practitioner 
such as: Age and Province of practice, data related to HIV claim such as, the date of HIV 
claim and that the general practitioner was a network doctor.  The percentage compliance was 
calculated using the HIV test claims for each unique pregnant woman who claimed divided 
by the number of pregnant women. According to Varkevisser et al., before and during data 
processing quality control checks are required to ensure completeness and internal 
consistency (38). The analysis of the data includes three statistical steps. 
Firstly, the data was sorted in Excel according to categories such as demographic data of the 
patient and general practitioner, pregnancy and HIV test data.  Categorical count of billing 
data and patient clinical data were used to determine trends and frequencies. Thereafter, a 
statistical analysis was performed on each variable for distribution of counts and the 
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numerical data was analysed to obtain means, range and standard deviation. Categorical data 
such as age bands were used to test the frequency distribution of the pregnant women per 
annum. Secondly, the data analysis paired variables that were relevant and stratified 
according to variables such as age, province, and income level of pregnant woman. This 
cross-tabulation was produced to show any association from the findings and for sensitivity 
analysis purposes to determine if there are any patterns.  
Thirdly, analysis was done to look for association between network versus non network 
general practitioner HIV testing screening rates using t-tests were used to check if the 
difference before and after the intervention was significant or not. The statistical significance 
was assessed at p<0.05 level. According to Gehlbach, statistical significance of p<0.05 helps 
rule out an important threat to validity and that the result could be due to chance rather than 
to real difference (39). Data is presented using tables, bar charts and pie charts.  
3.8. Validity and Reliability 
According to Rungtusanatham, content validity is established by determining the extent to 
which a measure reflects a specific domain of content (40). All claims and clinical data 
captured and processed on the Metropolitan Health billing system, production system is 
copied and loaded into the data warehouse on a daily or weekly basis, depending on the 
frequency of the specific transaction. This ensures that the data warehouse reflects up-to-date 
information, thus facilitating data analysis and trend reporting. 
All data that ends up on the operational data store (hereafter ODS) on the data warehouse 
coming from the Health Insurance Administrator Company’s operational system is 
extensively scrubbed in order to impart value from a reporting and statistical point of view. 
Various statistical models such as Statistical Package for the Social Science software, can 
utilise the data in the ODS and data marts to do in situ risk stratification of service providers 
and beneficiaries on the Health Insurance Administrator Company system.  
Pregnant women below the age of 15 and over the age of 55 were excluded due to possible 
data capture errors. Only HIV tests claimed 9 months prior to the expected date of delivery 
for any type of pregnancy (termination of pregnancy, miscarriage, normal vaginal delivery, 
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caesarean section) were included. Any HIV testing done prior to the nine months period of 
the pregnancy, or after the delivery would not be attributed to the study. The HIV test claim 
has to be linked to requesting general practitioners’; if no general practitioner is associated to 
the claim the record would be excluded. Possible reason could be a data capture error at the 
laboratory. The general practitioner must have agreed and contracted to the Health Insurance 
Administrator Company as a network general practitioner to have the network indicator 
added to his HIV test claim as part of the study. If the general practitioner is not indicated as 
network general practitioner his HIV testing claims will be counted as part of the non-
network group. Patients and general practitioners’ without accurate postal codes or provinces 
were highlighted and manually corrected by reviewing the original membership or general 
practitioner contract. Any missing income bands and ages of the patients or general 
practitioner was highlighted and corrected as mentioned above.   
Figure 1: Demonstrates the Health Insurance Information Management System (Source 
:Metropolitan Health) 
Figure 1 above illustrates how the clinical and claims data is collected and stored on the data 
warehouse for reporting analytics. The process is described below. 
 
 
 
 
 21 
 
There could be other confounding factors or co-intervention programmes implemented by 
competing healthcare companies that could affect the response of the exposed and unexposed 
groups. This would be difficult to establish unless known prior to the start of the project. As 
all pregnant women have access to antenatal care on medical aid due to prescribed minimum 
benefits, the ability to pay for healthcare service will not be a potential confounder. The 
quantitative data was counted and pivoted in Excel to create results or information from the 
data and then stratified using the Statistical Package for the Social Science software. 
 3.9.  Pilot Study 
A pilot study was conducted prior to the main data of the study to test the acceptance of the 
incentive by general practitioners’. This was done to test the reliability of the HIV testing portal 
and billing instrument and if general practitioners’ would agree offer HIV testing to pregnant 
women at an enhanced fee to compensate for additional time and effort required. In addition the 
pilot was conducted to determine the content validity of the billing and demographic data 
collected in MH billing system. 
 3.10.  Ethics considerations 
Polit et al. pointed out that research involving human beings may intend to advance 
knowledge, but should always adhere to the ethical rules that have been developed to protect 
rights of study participants (41). Permission to conduct the study and secondary data analysis 
was obtained from the General Manager of Out of Hospital at the Health Insurance 
Administrator Company (Appendix 1).An application for ethics approval was submitted, and 
was subsequently accepted by the University of the Western Cape Committee and Higher 
Degrees Committee (Appendix 2). In order to avoid any risk or harm to patients, no patient 
who consulted with a general practitioner was denied access to care as part of the study. The 
monetary incentive was over and above standard medical aid benefits as prescribed by the 
Medical Scheme Council. All participating general practitioners’ were trained by the 
researcher about the benefits of HIV screening and the process of accessing the incentive, via 
the web portal. In addition the data remained confidential and no identifiable information of 
the patient or general practitioners’ will be published to maintain anonymity. The 
intervention or incentive was already implemented and the research was analysing and 
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comparing the impact of incentive on the exposed and unexposed group of general 
practitioners’.  
3.11 Summary 
We were able to  analyse and evaluate the effects of the intervention by comparing pre- to 
post changes in the rate of HIV testing due to the intervention .The descriptive incidence rate 
of ANC screening rate of the at risk patients, namely pregnant women, was compared before 
and after the intervention was introduced. As mentioned above, the primary outcome of the 
study was only to measure successful HIV tests performed by the general practitioners’ on 
pregnant women. 
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CHAPTER FOUR: RESULTS 
In this chapter, the results of the study are presented. The first section contains a description 
of the study sample. Thereafter, the results from the finding will be presented according to 
the objectives of the study. Subsequently, statistical analysis will be covered in order to 
explore the associations between the different factors and the HIV testing rates of pregnant 
women in the private sector. 
4.1.  Description of study participants 
In total, 2 934 distinct network general practitioner were included in the analysis.  Figure 2 
illustrates the number of network doctors included per intervention period and the overlap  
 
Figure 2:  Number of network providers included for pre and post intervention analysis 
2 321 in Pre & Post 
intervention 
  
309 in Post 
intervention 
only 
304 in Pre 
intervention 
only 
2 625 in Pre intervention 
  
2 630 in Post intervention 
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Figure 2 above illustrates the number of general practitioners during the pre and post 
intervention stages. The pre intervention period included 2, 625 network general practitioners 
and post intervention period 2, 630 doctors.  A group of 2, 321 network doctors qualified for 
both pre and post intervention groups while 304 network doctors qualified only for the pre 
intervention period and 309 for the post intervention period. Only 25.2% of participating 
GP’s were between the age of 25 to 44 years.  Median age of the participating network 
general practitioners’ who performed HIV testing was 51 years (Inter Quartile Range (IQR): 
43-59 years), 58.36% of the particapting network general practitioners’ were between the age 
of 45-65 years as illustrated in table 3 below. With general practitioners’ over the age of 65 
years old representing 12.6% of the study participants.  
 
Table 3 : Age characteristics of participants (network general pracioners) 
 
Pre intervention 
period 
Post 
intervention 
period Overall 
  n (%) n (%) n (%) 
Network doctor, age in years       
   N 2 625 2 630  2934 
   Mean (SD) 54.86 (10.68) 51.16 (10.87) 51.43 (10.99) 
   Median (IQR) 51 (43-60) 51 (43-59) 51 (43-59) 
Network doctor, grouped per age 
categories (age in years?)       
   25-44 633 (24.11) 691 (26.27) 1 324  (25.20) 
   45-65 1 554 (59.20) 1 513 (57.53) 3 067  (58.36) 
   >65 341 (12.99) 321 (3.99) 662 (12.60) 
SD: Standard deviation  
IQR: Inter quartile range 
 4.2. Description of pregnant women 
A total of 67 507 distinct pregnant women contributed 71 066 records (pregnancy claims) for 
analysis, 35 969 pregnancy claims for pre intervention period and 35 097 pregnancy claims 
for post intervention period as illustrated in table 4. Nearly 50% of the pregnant women were 
from Gauteng and Kwazulu-Natal; representing 26.83 % and 21.66% respectively, of 
pregnant women included in the sample for analysis. The Eastern Cape and the Western Cape 
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represented 11.21% and 9.58% respectively, of pregnant women included in the sample for 
analysis. This provincial spread did not influence the outcome of the study and closely 
represented the normal population distribution of South Africa. 
Table 4: Demographic characteristics of pregnant women 
 
 
Pre intervention 
period 
Post intervention 
period 
Overall women 
included in 
analysis 
  n (%) n (%) n (%) 
Pregnant women 
records 35 969 (50.61) 35 097 (49.39) 71 066 
Pregnant women 
Province       
   Eastern Cape 4 196 (11.67) 3 774 (10.75) 7 970  (11.21) 
   Free State 2 392 (6.65) 2 494 (7.11) 4 886  (6.88) 
   Gauteng 9 814 (27.28) 9 251 (26.36) 19 065  (26.83) 
   Kwazulu Natal 7 432 (20.66) 7 961 (22.68) 15 393  (21.66) 
   Limpopo 3 147 (8.75) 3 422 (9.75) 6 569  (9.24) 
   Mpumalanga 1 773 (4.93) 1 532 (4.37) 3 305  (4.65) 
   North West 2 347 (6.53) 2 317 (6.6) 4 664  (6.56) 
   Northern Cape 1 225 (3.41) 1 183 (3.37) 2 408  (3.39) 
   Western Cape 3 643 (10.13) 3 163 (9.01) 6 806  (9.58) 
Age of pregnant women 
(unit) Pre intervention period 
Post intervention 
period Overall 
   Mean (SD) 29.74 (5.96) 30.21 (6.06) 29.96 (6.01) 
   Median (IQR) 30 (26-34) 30 (26-34) 30 (26-34) 
Beneficiary age category (unit) 
   15-19 2 008 (5.58) 1 893 (5.39) 3 901  (5.49) 
   20-24 4 669 (12.98) 4 190 (11.94) 8 859  (12.47) 
   25-29 10 820 (30.08) 9 595 (27.34) 20 415  (28.73) 
   30-34 10 378 (28.85) 10 758 (30.65) 21 136  (29.74) 
   35-39 6 383 (17.75) 6 515 (18.56) 12 898  (18.15) 
   40-44 1 613 (4.48) 2 035 (5.8) 3 648  (5.13) 
   45-49 96 (0.27) 108 (0.31) 204 (0.29) 
   50-54 2 (0.01) 3 (0.01) 5 (0.01) 
 
Beneficiary income category 
   Low 3 190 (8.87) 3 167 (9.02) 6 357 (8.95) 
   Medium 6 613 (18.39) 6 904 (19.67) 13 517  (19.02) 
   High 26 166 (72.75) 25 026 (71.31) 51 192  (72.03) 
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Beneficiaries could have contributed more than one record for analysis e.g. a pregnancy 
during pre and post intervention period or two pregnancies either during pre or post period.  
A total of 67 507 distinct pregnancy claims contributed 71 066 records (pregnancy claims) 
for analysis, 35 969 pregnancy claims for pre intervention period and 35 097 pregnancy 
claims for post intervention period.  A total of 2 476 women were pregnant twice contributed 
a pre and post pregnancy claim while 32 953 beneficiaries only contributed a pre intervention 
pregnancy claim and 32 078 contributed a post intervention pregnancy claim as illustrated by 
figure 3 below. Most of the deliveries occurred in the 25-29 years age group (28.73%), 30-34 
years (29.74%) and 35-39 years age group (18.15%). Teenage pregnancy for the ages 15-19 
years only represented 5.9% of pregnant population The median age of beneficiaries who 
delivered was 30 years (IQR: 26-34). Overall, 72.03% of patients were in the high income 
category, followed by medium income category (19.02%) and lastly low income category 
(8.95).  
Figure 3: Number of pregnant women included for pre and post intervention analysis 
2 476 in Pre &
Post
intervention 
32 078 in Post
intervention 
only 
32 953 in Pre 
intervention 
only 
35 429 in Pre intervention
34 554 in Post intervention
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Table 5: Delivery characteristics of pregnant women 
 
 
Factors 
Pre intervention 
period 
Post intervention 
period Overall 
 
n (%) n (%) n (%) 
Delivery type 
   Caesarean 22 002 (61.17) 22 141 (63.09) 44 143  (62.12) 
   Vaginal 9 122 (25.36) 7 913 (22.55) 17 035  (23.97) 
   Termination 4 845 (13.47) 5 043 (14.37) 9 888  (13.91) 
 
Table 5 above illustrates the high rate of caesarean section (62.12%) rates relative to vaginal 
(23.97%) and termination of pregnancy’s (13.91%).  
Table 6: Age group and delivery options pre and post intervention 
Table 6 above illustrates the termination rates are highest in pregnant women aged 45 to 49 
years old at 39.81% followed by 40 to 44 years old at 25.7% post intervention. Teenagers 
between the ages of 15 to 19 years old were terminating 16.0% of their pregnancies. 
 
 
Pre intervention Post intervention 
 
n (%) n (%) 
 Age (in 
years) Caesarean Vaginal Termination Caesarean Vaginal Termination 
15-19 1,052 (52.39) 650 (32.37) 306 (15.24) 958 (50.61) 631 (33.33) 304 (16.06) 
20-24 2,634 (56.41) 1,489 (31.89) 546 (11.69) 2,463 (58.78) 1,216 (29.02) 511 (12.2) 
25-29 6,583 (60.84) 2,906 (26.86) 1,331 (12.3) 6,009 (62.63) 2,391 (24.92) 1,195 (12.45) 
30-34 6,645 (64.03) 2,441 (23.52) 1,292 (12.45) 7,114 (66.13) 2,228 (20.71) 1,416 (13.16) 
35-39 4,091 (64.09) 1,311 (20.54) 981 (15.37) 4,328 (66.43) 1,136 (17.44) 1,051 (16.13) 
40-44 959 (59.45) 293 (18.16) 361 (22.38) 1,222 (60.05) 290 (14.25) 523 (25.7) 
45-49 37 (38.54) 32 (33.33) 27 (28.13) 47 (43.52) 18 (16.67) 43 (39.81) 
50-54 1 (50) 0 (0) 1 (50) 0 (0) 3 (100) 0 (0) 
Total 22,002 (61.17) 9,122 (25.36) 4,845 (13.47) 22,141 (63.09) 7,913 (22.55) 5,043 (14.37) 
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Table 7: HIV testing of pregnant women before and after the intervention 
Factors Pre 
intervention 
period 
Post 
intervention 
period 
Overall 
n (%) n (%) n (%) 
Beneficiaries 35 429 (52.48) 34 554 (51.18) 67 507(51.83) 
Beneficiary records 35 969 (50.61) 35 097 (49.39) 71 066 (50.01) 
Tested during pregnancy 
by network doctor 
7 908 (21.99) 7 708 (21.96) 15 616  (21.97) 
Table 7 illustrates that there was no statistical significant improvement of the HIV testing 
rates pre (21.99%) versus post (21.96%) intervention (p = 0.939).  
Figure 4: HIV testing was likely to be done for each delivery option 
Figure 4 illustrates the month of the pregnancy when women are likely to test for HIV when 
either have a Caesar or Vaginal delivery.  
For caesarean and vaginal delivery most of the HIV testing happened between months two 
and six of the pregnancy, peaking at month four. 
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A subset of pregnant women were identified who had more than one HIV test during the 
pregnancy period (n=5 406).  Routine antenatal care protocols from public sector suggest a 
second HIV test at 34 weeks if the patient was negative at the booking visit.  From Figure 5, 
it can be seen that second HIV tests were done mostly during the second and third trimester 
and the third HIV test, mostly in the third trimester. 
 
 
Figure 5: The frequency of repeat HIV testing during nine months of pregnancy  
Figure 5 above illustrates how many pregnant women had repeat HIV tests with 1 equating 
the first test, 2 represents the pregnant women who had two HIV tests and 3 represents the 
pregnant women who had three tests during their pregnancy  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 1 2 3 4 5 6 7 8 9
Pre
1 111 281 568 668 634 408 255 161 115 83
2 4 57 163 254 318 306 333 351 277
3 1 5 14 10 14 25 42 37
0
100
200
300
400
500
600
700
800
B
en
ef
ic
ia
ri
es
 
Number of months since estimated conception 
1
2
3
 
 
 
 
 30 
 
 
 
Table 8: characteristics of the general practitioner and pregnant women: pre versus post 
interventions by odds ratio and p value 
 
HIV testing Factors Odds ratio 95% CI (p value) 
HIV test done by network GP 
  Pre intervention 1   
Post intervention 0.98 0.87-1.09 (0.68) 
Network GP age category (years)     
25-44  1   
45-65 0.91 0.85-0.98 (0.01) 
>65 0.87 0.74-1.01 (0.07) 
Beneficiary age category (years)     
15-24 1   
25-34 1.04 1-1.08 (0.06) 
35-44 1.15 1.1-1.21 (<0.001) 
45-54 1.23 0.93-1.61 (0.15) 
Delivery type     
Caesarean 1   
Vaginal 0.87 0.84-0.9 (<0.001) 
Termination 1.02 0.98-1.07 (0.28) 
Beneficiary income category     
Low 1   
Medium 1.09 1.03-1.16 (0.004) 
High 0.97 0.92-1.02 (0.22) 
Beneficiary province     
Eastern Cape 1   
Free State 1.16 1.08-1.24 (<0.001) 
Gauteng 1.07 1.02-1.13 (0.01) 
Kwazulu-Natal 1.19 1.12-1.25 (<0.001) 
Limpopo 1.22 1.14-1.3 (<0.001) 
Mpumalanga 0.96 0.89-1.05 (0.38) 
North West 1.1 1.02-1.18 (0.01) 
Northern Cape 1.06 0.97-1.16 (0.21) 
Western Cape 0.97 0.91-1.04 (0.4) 
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Summary 
No significant difference in HIV testing by Network general practitioners’ was found pre and 
post the intervention (CI: 0.87 – 1.09) as illustrated in table 8 .  Compared to general 
practitioners’ aged 25-44 years, older doctors (indicate ages) were 13% less likely to test and 
general practitioners’ between 45 and 65 years were 9% less likely to do an HIV test . As 
pregnant women age increased they were more likely to be tested: participating pregnant 
women between the ages of 35 and 44 years were 15% more likely to be tested compared to 
15-24 year old women (OR 1.15, CI: 1.1-1.21).    
Beneficiaries who had a vaginal delivery were less likely to be tested compared to caesarean 
patients (OR 0.87, CI: 0.84-0.9).  Medium income beneficiaries were more likely to be tested 
compared to low income beneficiaries (OR 1.09, CI: 1.03-1.16) and beneficiaries from the 
“high income” scheme grouping were less likely to be tested (OR 0.87, CI: 0.82-0.92) 
compared to the low income scheme grouping.  Overall, Eastern Cape and Mpumalanga had 
the lowest testing rates compared to all the other provinces (OR 0.96, CI: 0.89-1.05). 
 
 
 
 
 
 
 
 
 
 
 
 
32 
CHAPTER FIVE: DISCUSSION 
In this section, the discussion attempts to explain and interpret the current study findings and 
compare the results to trends in similar studies. Therefore, discussion of the results will 
follow the following sub-groups: description of study participants, private sector pregnant 
women and of antenatal care in the private sector as well as the factors associated with the 
impact of the incentive. Lastly, this section will also acknowledge the limitations of this 
study.  
5.1. Description of study participants 
In total, 2934 distinct network general practitioners were included in the analysis, same 
population of general practitioners’ were used in the pre and post analysis. 
5.1.1.  Age of General Practitioners 
The median age of the network general practitioners’ in the study was 51 years (IQR 43-59). 
In addition over 75% of network general practitioners’ were over 45 years old, which 
illustrates an aging population of practising general practitioners’ within South Africa. This 
study found that compared to general practitioners’ aged 25-44 years, general practitioners’ 
older than 65 years old were 13% less likely to test (OR 0.87, CI: 0.74-1.01) and general 
practitioners’ between 45 and 65 years were 9% less likely to do an HIV test (OR 0.91, CI: 
0.85-0.98).   Thus the age of general practitioners’ was found to be a significant factor in low 
HIV testing rates, suggesting that older general practitioners’ (over 45-years ),  may have 
lower adherence rates of clinical guidelines than younger general practitioners’. Research by 
Adedeji et al., who analysed adherence of doctors to a clinical guideline for hypertension in 
South Africa, concurred that older doctors did not comply with clinical guidelines (43). Lee 
et al., also adherence to hypertension guidelines in Malaysia, found that more senior medical 
specialists' recommendations differed from national clinical practice guidelines (44).  More 
evidence from Brazil by  Vargas Sanos et al., found that older physicians, those with more 
than 10 years of practicing rheumatology or time since graduation from medical school 
showed a reduced chance of concordance to the guidelines (45). With a material number of 
older general practitioners’ practicing in the private sector, this may imply a reason why there 
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was no significant difference in HIV testing by network general practitioners’ pre and post 
the intervention. This suggests that there is a need for a study to understand why older 
general practitioners’ do not adhere to revised guidelines. 
5.2.   Description of Pregnant Women 
A total of 67 507 distinct pregnant women contributed 71 066 records (pregnancy claims) for 
analysis, 35 969 pregnancy claims were for pre intervention period and 35 097 pregnancy 
claims for post intervention period.  
5.2.1.  Lack of Contraception 
During the study a total of 2 476 beneficiaries were pregnant twice, once during pre-
intervention period and once again during post-intervention period. These 2476 women who 
fell pregnant again within the 21 months of the study represents 7% of the pre-intervention 
women ,who potentially , did not use family planning or protection to avoid falling pregnant 
again. According to the Department of Health’s contraception guideline, this guideline 
recommends that all postpartum women be counselled about contraception (46).  
According to Department of Health, after miscarriage or termination of pregnancy all women 
should be offered counselling and be provided with a contraceptive method of their choice 
from the full range of available methods (46). Early initiation of contraception is advisable 
because ovulation occurs as early as two weeks post- termination of pregnancy /miscarriage, 
so a woman can become pregnant almost immediately afterwards (46). Hence, it can be 
suggested that a future research study investigates the compliance of general practitioners’ to 
recommend contraception after pregnancy. These pregnancies were included in the study as 
each pregnancy is an opportunity to offer an HIV test. 
5.2.2.  Provincial Demographics of Pregnant Women 
Nearly 50% of the pregnant women were from Gauteng and Kwazulu-Natal representing 
26.83 % and 21.66% respectively, of pregnant women included in the sample for analysis. 
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According to the South African National Antenatal Survey, Gauteng and Kwazulu-Natal 
were one of the five provinces (Free State, Gauteng, KwaZulu-Natal, Mpumalanga and North 
West) out of the nine who recorded HIV prevalence estimates above the national estimate of 
29.5% (2).  
 5.2.3.  Age of pregnant women 
This study found the median age of the pregnant women was 30 years with an inter-quartile 
range of 26-34 years old. According to the South African National Antenatal survey, the HIV 
prevalence among women in the age group of 30 to 34 years remains the highest at 42.8% of 
pregnant women seeking antenatal care at public clinics (2). Thus the majority of women 
falling pregnant in South Africa aged 30-34 years are practising unprotected sex, falling 
pregnant and are therefore at risk of acquiring HIV.   
Nearly 18% of the pregnant women in this study were under the age of 24 years old; which 
suggests that these young women who had unprotected sex may not have had access to 
contraception and therefore maybe also be at a higher risk of acquiring HIV at a younger age. 
According to Flanagan et al., South Africa has one of the highest teenage pregnancy rates, 
with approximately 30% of 15 to19 year olds reportedly pregnant (47). In addition, when 
considering teenage pregnancy and gendered drivers looking at intergenerational sex is 
critical as it places teenage girls at particular risk of HIV due to inequalities of power, which 
is exacerbated by poverty (47). Hence, the need for future research to compare the reasons for 
teenage pregnancy in the private sector versus public sector as poverty may not be the main 
social determinant linked to teenage pregnancy in the private sector. 
This study highlights the importance and the need of HIV screening in the private sector of 
younger pregnant women.  
 5.2.4. Income levels of pregnant women 
Overall, 72.03% of patients were in the high income category, followed by medium income 
category (19.02%) and lastly low income category (8.95%).   A similar finding was identified 
in study by Panday et al., which suggests low income or poverty may not be linked to risk of 
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pregnancy in women with medical aid cover compared to the public sector women who do 
not have medical aid (48).  
5.2.5.  Pregnancy Delivery Options 
This study found that caesarean delivery (62.12%) occurred in almost two thirds of all cases 
and vaginal delivery in 23.97% of cases.  According to research by Bateman, who found that 
higher rates of potentially unnecessary procedures, particularly caesarean sections (C-
sections), were reported in private rather than at public settings (49). Bateman found that in 
South Africa, where 62%, confirming the finding from this study, of women delivering in the 
private sector had C-sections, compared with 18% in the public sector (49). Studies by 
Brugha et al., in Mexico suggested that fee-for-service payment structures (which are more 
heavily present in private than in public care delivery settings) incentivised increased C-
sections (50). This study found that termination of pregnancy represented 13.91 % of cases in 
the private sector. Table 6, illustrated that termination of pregnancy increased as beneficiary’s 
age increased, especially in the 40-year and older categories. Research by Henshaw, found 
that even in countries where contraception is commonly used and easily available, the 
number of unintended pregnancies remains high, with a large proportion of these unintended 
pregnancies end in abortion (51). South Africa similarly has free contraception for all 
women, despite this there are high rates of teenage pregnancies and unwanted pregnancies 
(46). Reasons for terminations can be due to various reasons especially in older women.  A 
study by Sivho et al., found that among older women (⩾35 years), who are in unstable 
relationship had a higher likelihood of abortion as well as due unsuitable work situation, 
higher education and being single (52). In addition the Sivho et al. study found that when a 
pregnancy is perceived as not suitable for the work situation, it is an important factor that 
influences the decision to have an abortion, especially for older women over the age of 35 
years old (52).  More research may be required to understand why older women in South 
Africa terminate pregnancies. 
5.3.  HIV testing rates of pregnant women 
HIV testing utilsaition rates by pregnant women maybe impacted by: timing and frequency 
rate of HIV testing, impact of pregnant womens age on HIV testing  rates,impact of delivery 
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options on HIV testing rates, and provincial trends of uptake of HIV testing among pregnant 
women,  these factors will be unpacked in turn. 
5.3.1. Timing and Frequency rates of HIV testing 
As illustrated in figure 4, for both caesarean and vaginal deliveries most of the testing 
happened between months two and six, peaking at month four. A subset of beneficiaries were 
identified who had more than one HIV test during the pregnancy period (n=5 406). Current 
guidelines in South Africa  recommend testing pregnant women for HIV antibodies at the 
first antenatal care visit, retesting at 32 weeks gestation and again at labor, with the goal of 
this testing being the early identification of both existing undiagnosed HIV infection as well 
as incident infections occurring during pregnancy (4). This testing intervention, combined 
with the 2013 World Health Organization (WHO) recommendations for early initiation of 
triple antiretroviral therapy (ART) as soon as HIV infection is identified in pregnant and 
breastfeeding women, is crucial to preventing mother to child transmission of HIV 
,preserving the mother’s health and reducing the number of HIV-infected children (53). 
From figure 5, it can be seen that second HIV tests were done mostly during the second and 
third trimester and the third HIV test mostly in the third trimester.  Possibly suggesting these 
pregnant women may be at high risk of acquiring HIV, thus being screened more regularly or 
that these general practitioners’ are compliant with HIV screening guidelines, more research 
is required to understand the trend of repeat testing.   
5.3.2.  Impact of pregnant womens age on HIV testing  rates 
In this study as beneficiary’s age increased they were more likely to be tested, e.g. 
beneficiaries between the age of 35 and 44 years were 15% more likely to be tested compared 
to 15-24 year old beneficiaries (OR 1.15, CI: 1.1-1.21).    
 
 
 
 
37 
A similar trend was found in a Sudanese study by Mahmoud et al., women older than 26 
years with more than one child, had a higher acceptance of HIV testing (54). Similarly, in a 
study conducted in Burkina Faso, by Pignatelli  et al., found the uptake rate of HIV testing 
rate increased linearly with age, being particularly low among adolescents (15-19 years) (55). 
It has been suggested that older women may be more aware of a higher cumulative risk of 
infection and are more likely to take autonomous decisions [55]. 
According to a study by Kirk et al., postmenopausal older women, with reduced estrogen 
levels, and atrophic vaginitis, are also aware of the increased risk for acquiring HIV infection 
[56]. This population of older adults is less likely to utilize barrier methods to prevent 
pregnancy or STIs [56].   
This contradicted findings by research done by Mkwanazi et al., who found that older and 
more educated women were less likely to accept testing, suggesting the need to specifically 
target these patients (16). The age of pregnant women agreeing to have a HIV test may be a 
confounder based on the evidence and research. 
The possible causes for the uptake in older women was not analysed in this study and may 
justify further research to understand why older women may take up HIV testing more 
readily compared to younger women. 
5.3.3. Impact of delivery options on HIV testing rates 
Beneficiaries who had a vaginal delivery were less likely to be tested compared to caesarean 
patients (OR 0.87, CI: 0.84-0.9).  According to resarch by Paul, existing prevention of mother 
to child programmes have four primary focus areas: routine HIV counselling and testing for 
all pregnant women, as well as anti-retroviral prophylaxis, avoidance of breast feeding for 
HIV infected women and the inclusion of caesarian section (57). 
The risk of transmission was 50% lower among women who delivered by caesarian section 
and a further 87% lower likelihood of transmission among women who underwent SCS and 
who received antiretroviral therapy during the antepartum, intrapartum, and postnatal periods 
(57). Thus, pregnant women who elect to have a caesarian section have a higher chance of 
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being offered HIV testing as part of the standard prevention of mother to child transmission 
programme. 
5.3.4. Provincial trends of uptake of HIV testing among pregnant women 
Overall, Eastern Cape and Mpumalanga had the lowest testing rates compared to all the other 
provinces (OR 0.96 CI: 0.89-1.05).All the other provinces aligned to the antenatal survey 
trends as illustrated in table 1 with Kwazulu-Natal ( Ante-natal HIV prevalence of 37.6%) 
being the highest to test for HIV in the private sector . This was not the case in Mpumalanga 
which has the second highest ante-natal survey prevalence at 26.6 % (2).  But in this study it 
had a the lowest rate of HIV testing , suggesting a poor compliance to HIV testing guidelines 
by private sector general practitioners’ despite the high prevalence on HIV in the public 
sector. This may justify a futher study intervention to increase testing rates in Mpumalanga. 
5.3.5.  Effect of Incentive on HIV testing uptake 
One of primary end points of the study was to determine if private sector general 
practitioners’ have the potential to change their clinical behaviour with respect to 
preventative HIV testing screening of pregnant women; and whether an incentive would 
motivate the general practitioners’ to initiate testing. 
Table 7 illustrates that there was no statistically significant improvement in HIV testing rates 
pre (21.99%) versus post (21.96%) intervention.  
Possible reasons could be due to lack of time, incentive was too small or lack of awareness of 
the latest clinical guidelines, these factors will be unpacked in turn 
5.3.5.1. Lack of time 
Lack of time could be  a reason why the incentive did not work , as confirmed by Armington, 
the normal estimated time involved in counselling and testing was  5 to 10 minutes, required 
for pre-test counselling, 5 to 20 minutes is required for post-test counselling, and a further 5 
to 20-minute processing time is required in between, depending on the test used (17).  Private 
sector general practitioners’ are more reluctant to accept an incentive if the process to access 
 
 
 
 
39 
the incentive prolongs their consultation time, affecting the workflow and ability to consult 
with more patients. 
In addition evidence by study done by Rayment et al., who also investigating barriers to 
implementation of HIV testing by clinical staff, found challenges in the provision of HIV 
testing, related to a lack of time to conduct testing and being ill-prepared to answer patient 
queries.  General practitioners’ felt that consent to test was too burdensome and time 
consuming to answer related questions (18). 
5.3.5 2. The incentive was too small 
The size of the incentive could be another reason the incentive did work  as confirmed by 
research performed by Dudley who found degree of change in the provider behaviour 
observed depended on many factors in addition but importantly to the amount of financial 
reward at stake (24). In addition Kenefick et al., also agreed that small incentives have been 
shown to be ineffective in changing healthcare provider behaviour (21). 
5.3.5.3. Lack of awareness of the latest guidelines 
In addition potentially, lack of awareness of the HIV testing guideline could be a contributing 
factor why the intervention did not work. As a systematic review of the effectiveness of 
healthcare in the National Health Service (by University of York in 1999 concluded that 
passive dissemination of clinical guidelines was generally ineffective (26).  
5.4. Limitations 
There are several limitations to the present study that may affect the validity and 
generalisability of the results. Therefore, the findings of this study must be interpreted in the 
light of the limitations.  
Firstly, due to gender and race not being a compulsory requirement to be registered as a 
network general practitioners’, we were unable to identify gender and race of the general 
practitioner  as a result this study was unable to attribute the impact of the intervention to race 
and gender of the general practitioners’. Secondly, due to race not being a compulsory 
requirement for patient to be registered on medical aid, we were unable to identify race of the 
pregnant  women, as a result this study was unable to attribute the impact of the intervention 
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relative  to race of the patients and the impact it may have on the general practitioners’ 
behaviour. Thirdly, the reasons general practitioners’ repeated HIV tests in small subset of 
pregnant women (n=5 406), was not obtained from the data as reasons for repeat testing was 
not part of the study objectives. Fourthly, as billing information was the primary source of 
data, the clinical results of the HIV test were unknown due to confidentiality and lack of 
access to the general practitioners’ patient folders. Fifthly, the possible reasons for non-
compliance was not measured such as lack of time, incentive was too small or lack of 
awareness of the latest clinical guidelines but could be part of future research. Finally, to 
access the financial incentive the general practitioners’ had to complete a data capture 
process on a web portal to access the financial incentive, this administrative burden and the 
time to counsel and wait for the result may have affected the uptake . Appendix 3 illustrates 
the portal questionnaire 
5.5. Summary 
The discussion dealt with the major findings of the study. Similarities with other studies with 
found with regards trends of HIV testing in pregnant women and the impact of financial 
incentives on general practitioners’ behaviour. The limitations of the study have also been 
described. The summary of the study, conclusion and recommendations based on the findings 
will be presented in the next chapter. 
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CHAPTER SIX: CONCLUSIONS AND RECOMMENDATIONS 
 6.1.  Conclusions 
The objectives of the study were to firstly determine if there was an increase in the uptake of 
HIV testing among pregnant women receiving antenatal care at general practitioner practices 
following the offering of a monetary incentive to the general practitioners, secondly to 
determine variations in the uptake of HIV testing based on characteristics of pregnant women 
and the general practitioner. 
 
The finding of this study concluded that the financial incentive did not prove effective in 
demonstrating an improvement in the quality of service aligned with a specific health 
outcome. 
The evidence of this study can be used to develop specific interventions aimed at older 
general practitioners’ practicing in the private sector. The finding of this research can 
contribute to developing an understanding of financial incentives and the impact on 
healthcare provider behaviour. It was evident that general practitioners’ in Mpumalanga 
required additional awareness of the benefits of routine HIV testing of pregnant women, 
considering the high HIV prevalence within that province at antenatal clinics. 
This study revealed that older women and women who had a caesarean section had a higher 
testing rate. It is evident that there are still some challenges to overcome in order to achieve 
the promotion of routine screening over targeted testing in the private sector. In addition the 
research can be used by future researchers in the field to conduct research and improve on the 
current study. Raising the quality of care in a health system will still require some form of 
incentive structure and clinical training support, both areas in which government has an 
important role, to ensure highest standards for care. General practitioners’ must still form part 
of the government’s national strategic plan to achieve higher quality of care across both 
public and private sectors. 
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 6.2.  Recommendations  
Recommendations are grouped into three themes, related to general practitioner Behaviour, 
Financial Incentives and Future Research. 
 6.2.1. General Practitioner Behaviour 
It emerged from this study that older general practitioners’ should be re-educated and 
informed about the benefits of HIV testing in pregnancy. The findings recommend general 
practitioners’ encourage all pregnant women whether they carry full term, miscarriage or 
have a termination of pregnancy are counselled and encouraged to be on a contraceptive 
method especially to protect the women from HIV. The findings has suggested that general 
practitioners’ in Mpumalanga should be proactive in promoting HIV screening of pregnant 
women considering the HIV prevalence rates within the public sector clinics. The findings 
has shown the need for general practitioners’ should be more vigilant in recommending HIV 
screening for all pregnant women but especially for pregnant women under the age of 34 
years old who according to the ante-natal survey are at highest risk of acquiring HIV. The 
study has noted that all general practitioners’ should encourage all pregnant women to 
comply with prevention of mother to child transmission programme which encourages HIV 
testing, ART and caesarean sections. 
 
 6.2.2.  Financial Incentives 
The study found no improvement in HIV testing before and after the intervention in the 
presence of a financial incentive, possible recommendations include; firstly, reducing the 
administrative burden to access the incentive in a simpler more user friendly form, secondly, 
the provision of rapid test kits that can produce a result in less than three minutes and finally, 
to provide varying levels of incentives to determine what amount is too low and what amount 
of incentive will result in acceptance.   
In addition maybe a multi-faceted intervention would provide to be more successful, as 
suggested by Davis et al., who recommended educational outreach meetings, opinion leaders, 
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patient-mediated interventions and reminders are likely to be more effective in changing 
healthcare provider behaviour, than just emailing guidelines (27). 
 6.2.3. Future Research 
As this study was a quantitative analysis using billing data, therefore there is a need to 
conduct a qualitative study to explore and describe the perceptions and knowledge of older 
general practitioners’ around the importance of HIV testing of pregnant women. Further 
research aimed at assessing the preference of incentives general practitioners’ are interested 
in may be linked to a change in HIV testing behaviour. 
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